BLRX is in the middle of an extending 3rd wave. Target is $1.34. If BLRX crosses $1.34 which is likely I will hold and reassess the trade. -AB
NMUS About: NEMUS Bioscience, Inc. ( NMUS ) , focused on the development of cannabinoid-based therapeutics to address global medical indications, especially those of unmet medical need. Entry better on 4h / 1d vs 1w chart here and another CBD stock missed entry for self note. Watching to see if breakout from current level. Future entry TBD. Watch...
$CELZ DD As It Stands, this is now one of my Long Term plays that I have added to my portfolio: I like what I see here and am glad to have the shares I have. Targeting BILLIONS IN REVENUE FOLKS AND THE TECHNOLOGY IS REAL AND PROVEN. AMAZING!!! WORTHY OF A MARKET CAP 50-100 MILLION TODAY THATS A PPS .104 - .208! Fellow investors it looks to me like...